160 related articles for article (PubMed ID: 8421650)
21. How we treat tumor lysis syndrome.
Muslimani A; Chisti MM; Wills S; Nadeau L; Zakalik D; Daw H; Huang J; Jaiyesimi I
Oncology (Williston Park); 2011 Apr; 25(4):369-75. PubMed ID: 21618960
[TBL] [Abstract][Full Text] [Related]
22. Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: consensus of an Italian expert panel.
Pession A; Masetti R; Gaidano G; Tosi P; Rosti G; Aglietta M; Specchia G; Porta F; Pane F
Adv Ther; 2011 Aug; 28(8):684-97. PubMed ID: 21779956
[TBL] [Abstract][Full Text] [Related]
23. Improving treatment for tumor lysis syndrome: strategies for every oncology nurse.
ONS News; 2004; 19(9 Suppl):43-4. PubMed ID: 15478582
[TBL] [Abstract][Full Text] [Related]
24. Tumor lysis syndrome in elderly.
Pumo V; Sciacca D; Malaguarnera M
Crit Rev Oncol Hematol; 2007 Oct; 64(1):31-42. PubMed ID: 17658268
[TBL] [Abstract][Full Text] [Related]
25. Tumor lysis syndrome in children with non-Hodgkin lymphoma.
Alavi S; Arzanian MT; Abbasian MR; Ashena Z
Pediatr Hematol Oncol; 2006; 23(1):65-70. PubMed ID: 16326415
[TBL] [Abstract][Full Text] [Related]
26. Features at presentation predict children with acute lymphoblastic leukemia at low risk for tumor lysis syndrome.
Truong TH; Beyene J; Hitzler J; Abla O; Maloney AM; Weitzman S; Sung L
Cancer; 2007 Oct; 110(8):1832-9. PubMed ID: 17724682
[TBL] [Abstract][Full Text] [Related]
27. Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome.
Davidson MB; Thakkar S; Hix JK; Bhandarkar ND; Wong A; Schreiber MJ
Am J Med; 2004 Apr; 116(8):546-54. PubMed ID: 15063817
[TBL] [Abstract][Full Text] [Related]
28. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus.
Cairo MS; Coiffier B; Reiter A; Younes A;
Br J Haematol; 2010 May; 149(4):578-86. PubMed ID: 20331465
[TBL] [Abstract][Full Text] [Related]
29. Spontaneous acute tumor lysis syndrome with advanced gastric cancer.
Woo IS; Kim JS; Park MJ; Lee MS; Cheon RW; Chang HM; Ahn JS; Lee JA; Park YI; Park YS; Shim JW; Yang I
J Korean Med Sci; 2001 Feb; 16(1):115-8. PubMed ID: 11289389
[TBL] [Abstract][Full Text] [Related]
30. Tumor lysis syndrome.
Tiu RV; Mountantonakis SE; Dunbar AJ; Schreiber MJ
Semin Thromb Hemost; 2007 Jun; 33(4):397-407. PubMed ID: 17525897
[TBL] [Abstract][Full Text] [Related]
31. Etiology and management of tumor lysis syndrome in patients with chronic lymphocytic leukemia.
Cheson BD
Clin Adv Hematol Oncol; 2009 Apr; 7(4):263-71. PubMed ID: 19521331
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin: a clinical review. Part II--Nursing assessment and management of side effects of cisplatin.
Cooley ME; Davis L; Abrahm J
Cancer Nurs; 1994 Aug; 17(4):283-93. PubMed ID: 7954376
[TBL] [Abstract][Full Text] [Related]
33. Tumor lysis syndrome after bortezomib therapy for plasma cell leukemia.
Jaskiewicz AD; Herrington JD; Wong L
Pharmacotherapy; 2005 Dec; 25(12):1820-5. PubMed ID: 16305302
[TBL] [Abstract][Full Text] [Related]
34. Overview of tumor lysis syndrome.
Doane L
Semin Oncol Nurs; 2002 Aug; 18(3 Suppl 3):2-5. PubMed ID: 12184049
[TBL] [Abstract][Full Text] [Related]
35. Pathophysiology, signs, and symptoms of acute tumor lysis syndrome.
Kaplow R
Semin Oncol Nurs; 2002 Aug; 18(3 Suppl 3):6-11. PubMed ID: 12184050
[TBL] [Abstract][Full Text] [Related]
36. Tumor lysis syndrome.
Cope DG
Clin J Oncol Nurs; 1999 Apr; 3(2):79-81. PubMed ID: 10633616
[No Abstract] [Full Text] [Related]
37. Ocular side effects of chemotherapy: nursing management.
Cloutier AO
Oncol Nurs Forum; 1992 Sep; 19(8):1251-9. PubMed ID: 1408967
[TBL] [Abstract][Full Text] [Related]
38. Oncological emergencies: tumor lysis syndrome.
Sobota J; Püsküllüoglu M; Zygulska AL
Przegl Lek; 2014; 71(4):210-4. PubMed ID: 25141580
[TBL] [Abstract][Full Text] [Related]
39. Incidence and pathogenesis of tumor lysis syndrome.
Locatelli F; Rossi F
Contrib Nephrol; 2005; 147():61-68. PubMed ID: 15604606
[TBL] [Abstract][Full Text] [Related]
40. Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature.
Hussain K; Mazza JJ; Clouse LH
Am J Hematol; 2003 Mar; 72(3):212-5. PubMed ID: 12605395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
